Diffuse dermal angiomatosis D21.9

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 10.11.2021

Dieser Artikel auf Deutsch

Synonym(s)

angioendotheliomatosis benigna; Angioendotheliomatosis inflammatory; Diffuse dermal angiomatosis; inflammatory angioendotheliomatosis; reactive angioendotheliomatosis

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Nurse and Tappeiner 1959

DefinitionThis section has been translated automatically.

Reactive, self-limited, realtively inflammatory, lymphoreticular disease that can occur in the context of systemic diseases such as bacterial endocarditis, rheumatoid arthritis, cryoglobulinemia, and monoclonal gammopathy. The disease is an expression of intravascular endothelial proliferation, mrist triggered by fibrin thrombus or cryoprotein thrombus.

Reactive angioendotheliomatosis must be distinguished from the malignant form of angioendotheliomatosis, which is considered intravascular lymphoma(intravascular cutaneous large cell lymphoma).

Occurrence/EpidemiologyThis section has been translated automatically.

Very rare; < 100 cases are described in world literature. No sex preference.

EtiopathogenesisThis section has been translated automatically.

Cryoglobulins, cold agglutinins and phospholipid antibodies were detected in a group of patients. In other cases, endoprophetic surgery was performed. A release of angiogenesis factors is assumed within the framework of the underlying disease.

LocalizationThis section has been translated automatically.

Mostly located on the trunk and extremities.

Clinical featuresThis section has been translated automatically.

Disease pattern limited to the skin, multifaceted and thus clinically not very groundbreaking. Mostly formation of solitary, asymptomatic, blurred, reticular or homogeneous extensive redness. But also disseminated, indurated, small or large plaques have been described, as well as subcutaneous nodules. More rare are papular or plaque-shaped exanthema interspersed with petechiae, sometimes with the aspect of a livedo.

HistologyThis section has been translated automatically.

Proliferation of densely packed solid and luminaceous capillaries that form networks in places. The vascular cavities are lined with clumsy endothelial cells that protrude into the lumens. No cell atypia, no increased proliferation tendency of the endothelial proliferates.

DiagnosisThis section has been translated automatically.

Clinic, histology, immunohistology.

Differential diagnosisThis section has been translated automatically.

Malignant angioendotheliomatosis (considered intravascular T-cell or B-cell lymphoma; histologic differentiation; systemic involvement).

Polyarteritis nodosa, cutaneous: palpable purpura, rarely livedo, urticarial exanthema, subcutaneous nodules with pyoderma gangraenosum-like ulcerations. Frequently pulmo-renal syndrome.

Erythema nodosum: acute; painful. Localization mainly on the lower legs.

Early forms of mycosis fungoides: Histology is diagnostic.

Kaposi's sarcoma (colour red-brown, arranged in the tension lines of the skin)

Angiosarcoma: mostly occurring in older people; development here in the area of prolonged lymphoedema (e.g. following mastectomy and lymphadenectomy), after radiotherapy and immunodeficiencies (e.g. HIV infection). When angiosarcomas occur after radiotherapy, the irradiation usually took place at least 5-6 years ago; longer intervals are not uncommon and can extend over decades.

Lymphangiosis carcinomatosa of visceral neoplasms: coarse clinically mostly uncharacteristic plaques.

TherapyThis section has been translated automatically.

Symptomatic

External therapyThis section has been translated automatically.

Wound cleansing and hydrocolloid dressings. Consistent protection against cold.

Internal therapyThis section has been translated automatically.

Symptomatic

Progression/forecastThis section has been translated automatically.

After treatment of the underlying disease: spontaneous healing under external wound therapy after a few months is possible. Recurrences are possible after 1-2 years at the latest.

LiteratureThis section has been translated automatically.

  1. Kleimann P (2017) Reactive angioendotheliomatosis. Nude Dermatol 44: 463-464
  2. Lazova RC et al (1996) Reactive angioendotheliomatosis. Amer J Dermatopathol 18: 63-69
  3. Mayor Ibarguren A et al (2014) Diffuse Reactive Angioendotheliomatosis
  4. Secondary to the Administration of Trabectedin and Pegfilgrastim. At J Dermatopathol PubMed PMID: 25140665.
  5. Satzger I et al (2009) Intravascular B-cell lymphomas. Dermatologist 60: 131-136
  6. Schmidt K et al (1996) Reactive angioendotheliomatosis in chronic lymphocytic leukemia. Dermatologist 47: 550-555
  7. Tollefson MM et al (2014) Diffuse dermal angiomatosis of the breast: Clinicopathologic study of 5 patients. J Am Acad Dermatol PubMed PMID: 25264238
  8. Wagner G (2007) Reactive angioendotheliomatosis after implantation of a shoulder joint prosthesis. Act Dermatol 33: 42-46
  9. Wallenfang K, Stadler R (2002) Angioendotheliomatosis. Nude Dermatol 28: 374-379
  10. Willemze R et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105: 3768-3785

Authors

Last updated on: 10.11.2021